Key Findings:  This review critically analyzed evidence on the therapeutic use of cannabinoids in psychiatry, highlighting potential benefits for anxiety, PTSD, and psychotic disorders, but emphasizing the need for larger, methodologically rigorous randomized trials to validate findings.
Type of Study:  Meta-analysis
Study Result:  Positive
Research Location(s):  Poland
Year of Pub:  2022
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Unspecified
Citation:  Silczuk A, et al. The Construct of Medical and Non-Medical Marijuana-Critical Review. Int J Environ Res Public Health. 2022; 19:(unknown pages). doi: 10.3390/ijerph19052769
Authors:  Silczuk A, Smułek D, Kołodziej M, Gujska J